Publications by authors named "T M Trippett"

Cancer alters the function of multiple organs beyond those targeted by metastasis. Here we show that inflammation, fatty liver and dysregulated metabolism are hallmarks of systemically affected livers in mouse models and in patients with extrahepatic metastasis. We identified tumour-derived extracellular vesicles and particles (EVPs) as crucial mediators of cancer-induced hepatic reprogramming, which could be reversed by reducing tumour EVP secretion via depletion of Rab27a.

View Article and Find Full Text PDF

We report herein an exploratory biomarker analysis of refractory tumors collected from pediatric patients before atezolizumab therapy (iMATRIX-atezolizumab, NCT02541604 ). Elevated levels of CD8 T cells and PD-L1 were associated with progression-free survival and a diverse baseline infiltrating T-cell receptor repertoire was prognostic. Differential gene expression analysis revealed elevated expression of CALCA (preprocalcitonin) and CCDC183 (highly expressed in testes) in patients who experienced clinical activity, suggesting that tumor neoantigens from these genes may contribute to immune response.

View Article and Find Full Text PDF
Article Synopsis
  • The MAPK pathway is being targeted in various tumors, and MEK1 inhibitors like cobimetinib are proposed to manage MAPK-dependent cancers in young patients.
  • The iMATRIX-cobi study evaluated the safety and anti-tumor effects of cobimetinib in children and young adults aged 6 months to 30 years with solid tumors linked to the MAPK pathway.
  • The results showed that while the safety profile for cobimetinib was similar to adults, only a few patients (5.4%) experienced partial tumor responses, indicating the need for further combination treatments to enhance effectiveness.
View Article and Find Full Text PDF

Effective reinduction regimens are needed for children with relapsed and refractory acute myeloid leukemia (AML), as outcomes remain poor. Therapeutic options are limited in this heavily pretreated patient population, many of whom have reached lifetime recommended doses of anthracycline chemotherapy. The development of effective non-anthracycline-based salvage regimens is crucial to these patients who are at significant risk of life-threatening cardiotoxicity.

View Article and Find Full Text PDF

Background: To assess the spectrum and frequency of modalities used for emergency room (ER) imaging and their findings in pediatric cancer patients and assess their relationship with survival.

Methods: Consecutive pediatric cancer patients that underwent imaging during an ER visit at our tertiary cancer center over a 5-year period were retrospectively analyzed. Imaging findings were considered positive when they were relevant to the ER presenting complaint.

View Article and Find Full Text PDF